Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas

Neuroscience Letters

Volumn 494, Issue 1, 2011, Pages 34-37

  Hashimoto, Koshi ^a   Matsumoto, Shunichi ^a   Ishida, Emi ^a   Miura, Atsuko ^a   Horiguchi, Kazuhiko ^a   Ozawa, Atsushi ^a   Shibusawa, Nobuyuki ^a   Satoh, Teturou ^a   Yamada, Masanobu ^a   Yamada, Shozo ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

ACTH secreting pituitary adenoma; Human pituitary adenomas; Liver X receptor; POMC gene expression

Indexed keywords

CORTICOTROPIN; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; PRO-OPIOMELANOCORTIN; RNA, MESSENGER;

EID: 79953053633     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.02.048     Document Type: Article

References (23)

1. Apfel R., Benbrook D., Lernhardt E., Ortiz M.A., Salbert G., Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 1994, 14:7025-7035.
2. Bertagna X., Guignat L., Groussin L., Bertherat J. Cushing's disease. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:607-623.
3. Biller B.M., Grossman A.B., Stewart P.M., Melmed S., Bertagna X., Bertherat J., Buchfelder M., Colao A., Hermus A.R., Hofland L.J., Klibanski A., Lacroix A., Lindsay J.R., Newell-Price L., Nieman L.K., Petersenn S., Sonino N., Stalla G.K., Swearingen B., Vance M.L., Wass J.A., Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 2008, 93:2454-2462.
4. Bjorkhem I., Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?. Arterioscler. Thromb. Vasc. Biol. 2002, 22:734-742.
5. Chisholm J.W., Hong J., Mills S.A., Lawn R.M. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res. 2003, 44:2039-2048.
6. Cummins C.L., Volle D.H., Zhang Y., McDonald J.G., Sion B., Lefrancois-Martinez A.M., Caira F., Veyssiere G., Mangelsdorf D.J., Lobaccaro J.M. Liver X receptors regulate adrenal cholesterol balance. J. Clin. Invest. 2006, 116:1902-1912.
7. Hashimoto K., Ishida E., Matsumoto S., Shibusawa N., Okada S., Monden T., Satoh T., Yamada M., Mori M. A liver X receptor (LXR)-beta alternative splicing variant (LXRBSV) acts as an RNA co-activator of LXR-beta. Biochem. Biophys. Res. Commun. 2009, 390:1260-1265.
8. Hashimoto K., Ishida E., Miura A., Ozawa A., Shibusawa N., Satoh T., Okada S., Yamada M., Mori M. A liver X receptor (LXR)-beta alternative splicing variant (LXRBSV) is preferentially expressed in the pituitary. Biochem. Biophys. Res. Commun. 2010, 394:548-552.
9. Heaney A.P., Fernando M., Yong W.H., Melmed S. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nat. Med. 2002, 8:1281-1287.
10. Horiguchi K., Yamada M., Satoh T., Hashimoto K., Hirato J., Tosaka M., Yamada S., Mori M. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue. Clin. Cancer Res. 2009, 15:2620-2629.
11. Höybye C., Grenbäck E., Rähn T., Degerblad M., Thorén M., Hulting A.L. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 2001, 49:284-291.
12. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 2003, 9:213-219.
13. Mampalam T.J., Tyrrell J.B., Wilson C.B. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann. Intern. Med. 1988, 109:487-493.
14. Matsumoto S., Hashimoto K., Yamada M., Satoh T., Hirato J., Mori M. Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary. Mol. Endocrinol. 2009, 23:47-60.
15. Nilsson M., Stulnig T.M., Lin C.Y., Yeo A.L., Nowotny P., Liu E.T., Steffensen K.R. Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. Mol. Endocrinol. 2007, 21:126-137.
16. Oldfield E.H., Doppman J.L., Nieman L.K., Chrousos G.P., Miller D.L., Katz D.A., Cutler G.B., Loriaux D.L. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N. Engl. J. Med. 1991, 325:897-905.
17. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 2000, 16:459-481.
18. Stulnig T.M., Steffensen K.R., Gao H., Reimers M., Dahlman-Wright K., Schuster G.U., Gustafsson J.A. Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol. Pharmacol. 2002, 62:1299-1305.
19. Tamura K., Chen Y.E., Horiuchi M., Chen Q., Daviet L., Yang Z., Lopez-Ilasaca M., Mu H., Pratt R.E., Dzau V.J. LXR alpha functions as a cAMP-responsive transcriptional regulator of gene expression. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8513-8518.
20. Tateno T T., Izumiyama H., Doi M., Yoshimoto T., Shichiri M., Inoshita N., Oyama K., Yamada S., Hirata Y. Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. Eur. J. Endocrinol. 2007, 157:717-724.
21. Umesono K., Murakami K.K., Thompson C.C., Evans R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991, 65:1255-1266.
22. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995, 9:1033-1045.
23. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 2006, 116:607-614.